Commentary Open Access
Volume 5 | Issue 1 | DOI: https://doi.org/10.46439/cardiology.5.29
Should the cardiac heart valve prosthesis type choice also consider the valve size at the intraoperatively? Commentary on recent researches about sequential valve-in-valve
Caio Cesar Cardoso1,*
- 1Federal University of São Paulo, São Paulo, Brazil
Corresponding Author
Caio Cesar Cardoso, caiocesarcardoso@yahoo.com.br
Received Date: February 27, 2025
Accepted Date: March 27, 2025
Cardoso CC. Should the cardiac heart valve prosthesis type choice also consider the valve size at the intraoperatively? Commentary on recent
researches about sequential valve-in-valve. Int J Cardiol Cardiovasc Dis. 2025;5(1):6-8.
Copyright: © 2025 Cardoso CC. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Improving cardiac rehabilitation referral rates in patients with coronary heart disease from diverse communities using an electronic order system
Cardiac Rehabilitation (CR) is a medically supervised preventative cardiovascular program that involves a multi-disciplinary approach including physician-prescribed exercises, cardiac risk factor modification (education, counseling, and behavioral intervention), psycho-social assessment, outcomes assessment, and individual treatment plans [1,2].
Retrospective evaluation of heart failure verification and relation to readmission and all-cause mortality in a community-based cohort
The use of administrative databases to determine predictors for heart failure (HF) readmission, cardiovascular, or all-cause mortality (ACM) requires HF coding that is verifiable. It is assumed that administrative databases have HF verified via coders based on physician documentation and additional criteria.
Review of delayed sternal closure after congenital heart surgery
Since introduced for the first time in 1975 by Riahi et al, delayed sternal closure (DSC) remains a commonly utilized strategy in congenital heart surgery (CHS) for patients with anticipated hemodynamic instability based upon complexity of the performed procedure or in patients who exhibit instability during surgery [1].
Shared care left ventricular assist device site to implant center: the next step in advanced heart failure treatment and an essential part of healthcare worldwide
Heart failure is a growing pandemic affecting approximately 6.2 million people in the US and 15 million people worldwide. Given its prevalence, high morbidity and mortality, and financial burden on our healthcare system, establishing strategies focused on improving therapeutic outcomes and prognosis has become a major priority.
Omecamtiv mecarbil for heart failure: Unpacking the latest systematic review and meta-analysis
In February 2023, a systematic review and meta-analysis of six randomized controlled trials (RCTs) with a total of 9,596 patients assessed the effectiveness and safety of omecamtiv mecarbil (OM) versus placebo in patients with heart failure with reduced left ventricular ejection fraction (HFrEF) [1].